Purpose: To develop a multi-modal model combining multi-sequence breast MRI fusion radiomics and deep learning for the classification of benign and malignant breast lesions, to assist clinicians in better selecting treatment plans.

Methods: A total of 314 patients who underwent breast MRI examinations were included. They were randomly divided into training, validation, and test sets in a ratio of 7:1:2. Subsequently, features of T1-weighted images (T1WI), T2-weighted images (T2WI), and dynamic contrast-enhanced MRI (DCE-MRI) were extracted using the convolutional neural network ResNet50 for fusion, and then combined with radiomic features from the three sequences. The following models were established: T1 model, T2 model, DCE model, DCE_T1_T2 model, and DCE_T1_T2_rad model. The performance of the models was evaluated by the area under the receiver operating characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, positive predictive value, and negative predictive value. The differences between the DCE_T1_T2_rad model and the other four models were compared using the Delong test, with a -value < 0.05 considered statistically significant.

Results: The five models established in this study performed well, with AUC values of 0.53 for the T1 model, 0.62 for the T2 model, 0.79 for the DCE model, 0.94 for the DCE_T1_T2 model, and 0.98 for the DCE_T1_T2_rad model. The DCE_T1_T2_rad model showed statistically significant differences ( < 0.05) compared to the other four models.

Conclusion: The use of a multi-modal model combining multi-sequence breast MRI fusion radiomics and deep learning can effectively improve the diagnostic performance of breast lesion classification.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536030PMC
http://dx.doi.org/10.1016/j.ejro.2024.100607DOI Listing

Publication Analysis

Top Keywords

breast mri
16
dce_t1_t2_rad model
16
model
15
multi-sequence breast
12
mri fusion
12
fusion radiomics
12
radiomics deep
12
deep learning
12
classification benign
8
benign malignant
8

Similar Publications

Purpose: Response Evaluation Criteria in Solid Tumours (RECIST) determines partial response (PR) and progressive disease (PD) as a 30 % reduction and 20 % increase in the longest diameter (LD), respectively. Tumour volume analysis (TVA) utilises three diameters to calculate response parameters.

Patients And Methods: We conducted a pilot investigation of patients who underwent neoadjuvant breast cancer treatment and evaluation using RECIST with LD measurements and TVA with three diametric measurements, using the parameters PR (>30 % tumour regression), PD (>20 % tumour growth), and intermediate stable disease (SD).

View Article and Find Full Text PDF

The Role of Positron Emission Tomography Imaging in Breast Implant Illness.

Plast Reconstr Surg Glob Open

January 2025

From the Section General Internal Medicine, Department of Internal Medicine, Amsterdam Public Health Research Institute, Amsterdam University Medical Centers, Amsterdam, The Netherlands.

Background: Explantation often alleviates symptoms in women with breast implant illness. However, persistent complaints in some cases may be linked to persistent silicone-induced inflammation from residual silicone particles. Positron emission tomography (PET) imaging could potentially detect this inflammation.

View Article and Find Full Text PDF

Our case report characterizes a rare presentation of mid-ventricular Takotsubo cardiomyopathy (TTC) in a patient with suspected myocarditis as an underlying cause. Mid-ventricular TTC is a rare variant of TTC presenting with overlapping symptoms and physical exam findings of acute coronary syndrome, which often leads to misdiagnosis as myocardial infarction. Our case is of a 77-year-old female patient with a history of hyperlipidemia, right breast ductal carcinoma in situ, and diverticular disease who presented to the emergency department for evaluation of chest pain radiating to the jaw with associated nausea and vomiting.

View Article and Find Full Text PDF

Background: Axillary lymph node metastasis (ALNM) is a significant predictor of overall patient survival; thus, precise evaluation of ALNM is essential for staging breast cancer, informing multimodal treatment strategies, and ensuring optimal patient care. This study aimed to establish a magnetic resonance imaging (MRI) scoring system for predicting extensive axillary nodal metastasis in patients with clinically node-negative breast cancer derived from preoperative breast and axillary MRI.

Methods: This study included 226 patients with clinically node-negative breast cancer who underwent preoperative breast and axillary MRI between January 1, 2010 and December 31, 2020 at King Chulalongkorn Memorial Hospital.

View Article and Find Full Text PDF

Background: Breast cancer is the most common malignant tumor among women, with an increasing incidence each year. The subtypes of human epidermal growth factor receptor 2 (HER2)-negative breast cancer, classified as HER2-low and HER2-zero based on HER2 receptor expression, show differences in clinical characteristics, therapeutic approaches, and prognoses. Distinguishing between these subtypes is clinically valuable as it can impact treatment strategies, including the use of next-generation antibody-drug conjugates (ADCs) targeting HER2-low tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!